Clinical Trial NCT06715943

Trial

Chengdu Suncadia Medicine – HRS-5965-302 (NCT06715943)

Clinical trial ID

NCT06715943

Drug name

HRS-5965

Company:

Chengdu Suncadia Medicine Co., Ltd

Drug trade name

Clinicaltrials.gov

Learn more

Phase of study

3

Current status

Recruiting

Start

12/2024

Substance

HRS‑5965 (capsules)

Research question

Can HRS‑5965 capsules improve anemia in PNH patients who remain anemic despite ≥6 months of C5 inhibitor therapy?

Delivery method of drug

Frequency

Clinical trial locations

China